Jeffrey T. Kohrt

1.2k total citations
23 papers, 821 citations indexed

About

Jeffrey T. Kohrt is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Jeffrey T. Kohrt has authored 23 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Jeffrey T. Kohrt's work include Catalytic C–H Functionalization Methods (5 papers), Synthesis and Catalytic Reactions (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Jeffrey T. Kohrt is often cited by papers focused on Catalytic C–H Functionalization Methods (5 papers), Synthesis and Catalytic Reactions (4 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). Jeffrey T. Kohrt collaborates with scholars based in United States, United Kingdom and Austria. Jeffrey T. Kohrt's co-authors include M. Christina White, Thomas J. Osberger, Donald C. Rogness, Antonia F. Stepan, Usa Reilly, Kaibo Feng, Martins S. Oderinde, Vincent Mascitti, David C. Blakemore and Kevin D. Hesp and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Jeffrey T. Kohrt

23 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey T. Kohrt United States 14 614 182 176 153 43 23 821
Martyn Inman United Kingdom 12 792 1.3× 233 1.3× 119 0.7× 38 0.2× 37 0.9× 20 1.0k
Yuan Cai China 17 785 1.3× 196 1.1× 291 1.7× 77 0.5× 10 0.2× 39 1.0k
Kouichi Uoto Japan 18 517 0.8× 389 2.1× 83 0.5× 76 0.5× 14 0.3× 45 939
Milan Bruncko United States 14 499 0.8× 433 2.4× 106 0.6× 37 0.2× 32 0.7× 22 884
Guo‐Shu Chen China 21 1.4k 2.3× 194 1.1× 316 1.8× 131 0.9× 8 0.2× 60 1.6k
Paul M. Wehn United States 11 1.0k 1.6× 341 1.9× 150 0.9× 32 0.2× 30 0.7× 15 1.3k
Harald Weinstabl Austria 16 675 1.1× 154 0.8× 85 0.5× 30 0.2× 10 0.2× 32 862
Mark P. Healy United Kingdom 14 694 1.1× 392 2.2× 423 2.4× 50 0.3× 10 0.2× 24 1.2k
Joey L. Methot United States 12 1.0k 1.7× 367 2.0× 312 1.8× 46 0.3× 35 0.8× 17 1.2k
Guolin Zhang China 19 593 1.0× 247 1.4× 41 0.2× 45 0.3× 46 1.1× 61 950

Countries citing papers authored by Jeffrey T. Kohrt

Since Specialization
Citations

This map shows the geographic impact of Jeffrey T. Kohrt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey T. Kohrt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey T. Kohrt more than expected).

Fields of papers citing papers by Jeffrey T. Kohrt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey T. Kohrt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey T. Kohrt. The network helps show where Jeffrey T. Kohrt may publish in the future.

Co-authorship network of co-authors of Jeffrey T. Kohrt

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey T. Kohrt. A scholar is included among the top collaborators of Jeffrey T. Kohrt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey T. Kohrt. Jeffrey T. Kohrt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baldwin, Aaron F., Shawn Cabral, Jeffrey T. Kohrt, et al.. (2023). Route Optimization of the Non-covalent Modulator of Hemoglobin PF-07059013 for the Treatment of Sickle Cell Disease, Part I: From Discovery Synthesis to First Kilogram-Scale Manufacture. Organic Process Research & Development. 27(5). 854–865. 2 indexed citations
2.
Ren, Xinkun, et al.. (2022). Enantioselective Single and Dual α-C–H Bond Functionalization of Cyclic Amines via Enzymatic Carbene Transfer. Journal of the American Chemical Society. 145(1). 537–550. 24 indexed citations
3.
Feng, Kaibo, et al.. (2020). Late-stage oxidative C(sp3)–H methylation. Nature. 580(7805). 621–627. 164 indexed citations
4.
Schwarz, Anna, et al.. (2020). Cell‐free in vitro reduction of carboxylates to aldehydes: With crude enzyme preparations to a key pharmaceutical building block. Biotechnology Journal. 16(4). e2000315–e2000315. 11 indexed citations
5.
Zhang, Qing‐Wei, Andrew T. Brusoe, Vincent Mascitti, et al.. (2016). Fluorodecarboxylation for the Synthesis of Trifluoromethyl Aryl Ethers. Angewandte Chemie International Edition. 55(33). 9758–9762. 87 indexed citations
6.
Osberger, Thomas J., Donald C. Rogness, Jeffrey T. Kohrt, Antonia F. Stepan, & M. Christina White. (2016). Oxidative diversification of amino acids and peptides by small-molecule iron catalysis. Nature. 537(7619). 214–219. 239 indexed citations
7.
Zhang, Qing‐Wei, Andrew T. Brusoe, Vincent Mascitti, et al.. (2016). Fluorodecarboxylation for the Synthesis of Trifluoromethyl Aryl Ethers. Angewandte Chemie. 128(33). 9910–9914. 25 indexed citations
8.
Kohrt, Jeffrey T., et al.. (2013). Expedient synthesis of novel β-ketoesters from the Mizoroki–Heck coupling of ethyl 3-ethoxyacrylate with aryl and pyridyl halides. Tetrahedron Letters. 54(51). 7065–7068. 1 indexed citations
9.
Powell, Noel A., Fred L. Ciske, Jeffrey T. Kohrt, et al.. (2012). Optimization of highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase. Bioorganic & Medicinal Chemistry Letters. 23(4). 1051–1055. 12 indexed citations
10.
Powell, Noel A., Fred L. Ciske, Michael D. Kaufman, et al.. (2012). Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase. Bioorganic & Medicinal Chemistry Letters. 23(4). 1046–1050. 13 indexed citations
11.
Huard, Kim, Scott W. Bagley, Elnaz Menhaji‐Klotz, et al.. (2012). Synthesis of Spiropiperidine Lactam Acetyl-CoA Carboxylase Inhibitors. The Journal of Organic Chemistry. 77(22). 10050–10057. 26 indexed citations
12.
Powell, Noel A., Jeffrey T. Kohrt, Kevin J. Filipski, et al.. (2011). Novel and selective spiroindoline-based inhibitors of sky kinase. Bioorganic & Medicinal Chemistry Letters. 22(1). 190–193. 44 indexed citations
13.
Casimiro‐Garcia, Agustin, Christopher F. Bigge, Wayne L. Cody, et al.. (2009). Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action. Bioorganic & Medicinal Chemistry. 17(6). 2501–2511. 17 indexed citations
14.
Larsen, Scott D., Kevin J. Filipski, Jeffrey T. Kohrt, et al.. (2007). Pyrazole inhibitors of HMG-CoA reductase: An attempt to dramatically reduce synthetic complexity through minimal analog re-design. Bioorganic & Medicinal Chemistry Letters. 17(20). 5567–5572. 11 indexed citations
15.
Kohrt, Jeffrey T., et al.. (2006). The Discovery of Fluoropyridine‐Based Inhibitors of the Factor VIIa/TF Complex.. ChemInform. 37(4). 1 indexed citations
16.
Filipski, Kevin J., Jeffrey T. Kohrt, Agustin Casimiro‐Garcia, et al.. (2006). A versatile copper-catalyzed coupling reaction of pyridin-2(1H)-ones with aryl halides. Tetrahedron Letters. 47(44). 7677–7680. 47 indexed citations
17.
Kohrt, Jeffrey T., Kevin J. Filipski, Wayne L. Cody, et al.. (2005). The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2. Bioorganic & Medicinal Chemistry Letters. 16(4). 1060–1064. 10 indexed citations
18.
Kohrt, Jeffrey T., Kevin J. Filipski, Stephen T. Rapundalo, Wayne L. Cody, & Jeremy J. Edmunds. (2000). An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen-2-yl)-5-((2,2-methylpropyl)carbamoyl)benzoic acid: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company. Tetrahedron Letters. 41(32). 6041–6044. 24 indexed citations
19.
Bates, Dallas K., et al.. (1997). FUSED PYRAZOLE SYNTHESIS BY N-N BOND FORMATION: THE PYRAZOLO[5,1-b]BENZOTHIAZOLE SYSTEM. Heterocyclic Communications. 3(3). 201–206. 4 indexed citations
20.
Barrett, Anthony G. M. & Jeffrey T. Kohrt. (1995). Model Studies on the Synthesis of Hennoxazole A. Synlett. 1995(5). 415–416. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martyn Inman Breakdown of academic impact, for papers by Yuan Cai Breakdown of academic impact, for papers by Kouichi Uoto Breakdown of academic impact, for papers by Milan Bruncko Breakdown of academic impact, for papers by Guo‐Shu Chen Breakdown of academic impact, for papers by Paul M. Wehn Breakdown of academic impact, for papers by Harald Weinstabl Breakdown of academic impact, for papers by Mark P. Healy Breakdown of academic impact, for papers by Joey L. Methot Breakdown of academic impact, for papers by Guolin Zhang
Rankless by CCL
2026